Pharma

Your Article Summary

See Latest Articles

Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Medtronic, 06/25/09

Each year, approximately 795,000 people experience a new or recurrent stroke1 in the United States, and approximately a half million people in Western Europe are similarly afflicted. Medtronic Inc. announces two significant clinical trials related to medical device interventions for stroke. First enrollments in the global CRYSTAL AF trial have taken place. The trial will use the Reveal XT Insertable Cardiac Monitor to assess the incidence of atrial fibrillation in patients with cryptogenic stroke or transient ischemic attack in order to aid physicians in determining the optimal course of treatment for these patients.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/09/09

The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
Trials, 12/09/09

Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial
The Lancet - Early Online Publication, 12/09/09

 See all of Drug Trials